Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-008819

CVP, Critical Care sold 5,000 shares at $76.00 ($380,000)

  • CVP, Critical Care acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Szyman Catherine M. · CVP, Critical Care

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-08 Exercise or conversion : show line 1 in the form 10b5-1 +5,000 $36.75 $183,750 39,813.57 D
2023-09-08 Sale : show line 2 in the form 10b5-1 −5,000 $76.00 $380,000 34,813.57 D
Open-market sales · 5,000 sh · avg $76.00 · $380,000

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-08 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −5,000 $36.75 2024-05-10 5,000 52,000 D
Loading xslF345X05/doc4.xml…